All of the freshest reports have the Genzyme Corporation (NASDAQ: GENZ) buyout discussions between Sanofi-Aventis (NYSE: SNY) as being a friendly merger. The first discussions noted by the WSJ were a $67 to $70…
Pfizer Inc. (NYSE: PFE) is out with earnings of $0.62 EPS on an adjusted basis on 58% growth in revenues (due to Wyeth purchase) of $17.33 billion in revenues. Thomson Reuters had estimates of…
Allergan (NYSE: AGN) announced its second quarter earnings and a dividend of $.05 a share. The company can afford it. Allergan made $242 million in net income on $1.27 billion in sales. The specialty…
Boston Scientific Corporation (NYSE: BSX) has been a long and painful investment for thousands of shareholders who have held shares in hopes that this turnaround stock can eventually turn around. News yesterday out of…
Updated throughout the day. Genzyme (NASDAQ: GENZ) is considering an offer from Sanofi-Aventis (Reuters) Clayton Dubilier & Rice and Goldman Sachs’s private-equity unit are negotiating to buy Harrington Holdings (Bloomberg) Douglas A. McIntyre
Genzyme Corporation (NASDAQ: GENZ) is flying high on reports that Sanofi-Aventis (NYSE: SNY) may have an interest in buying the company. The WSJ reports that the large drug giant has approached what was the…
This weekend’s edition of The Unusual Suspects includes mostly non-earnings events that will be on deck this coming week and/or some of the carry-over issues from last week. Our list of Unusual Suspects to…
Properly used, home health care can save billions of dollars annually in health care expenditures. Sending a patient home and then sending a professional nurse or therapist to visit them periodically is far cheaper…
GlaxoSmithKline (NYSE: GSK), like a number of pharmaceutical companies before it, has run up against the truth about one of its drugs. According to The New York Times, “In the fall of 1999, the…
Merck & Co., Inc. (NYSE: MRK) will dump 16,000 workers now that its merger with Schering-Plough well along. The company announced plans to phase out operations at eight research sites and eight manufacturing sites,…
Today’s version of the BioHealth Business Daily is a very unusual lot of movers. Some moves are merely in sympathy and some are on news. We also have a re-review of Amgen Inc. (NASDAQ:…
Sanofi-Aventis SA (NYSE: SNY) was a bit of a stalking horse news item on a week that many investors and traders started taking off for a long weekend. The company has tried to telegraph…
Heavy losses were sustained in three Tickerspy indexes over the last 30-day period. This month’s biggest index losers are in radio, Chinese advertising, and cancer treatment stocks. Radio stocks are down 15.2% in the past…
If there is one single sector which could be immune to the crummy jobs data, it is biotech. Just don’t look at Dendreon Corporation (NASDAQ: DNDN) for much warmth today. There is not any…
There are many key movers in today’s BioHealth Business Daily. We have included background data, news, reactions, and added in color where applicable. BioHealth stocks to watch today are Amgen Inc. (NASDAQ: AMGN), Amylin…